1. Home
  2. MOGO vs NRSN Comparison

MOGO vs NRSN Comparison

Compare MOGO & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MOGO
  • NRSN
  • Stock Information
  • Founded
  • MOGO 2003
  • NRSN 2017
  • Country
  • MOGO Canada
  • NRSN Israel
  • Employees
  • MOGO N/A
  • NRSN N/A
  • Industry
  • MOGO
  • NRSN Biotechnology: Pharmaceutical Preparations
  • Sector
  • MOGO
  • NRSN Health Care
  • Exchange
  • MOGO Nasdaq
  • NRSN Nasdaq
  • Market Cap
  • MOGO 37.1M
  • NRSN 29.8M
  • IPO Year
  • MOGO N/A
  • NRSN 2021
  • Fundamental
  • Price
  • MOGO $1.43
  • NRSN $0.93
  • Analyst Decision
  • MOGO Strong Buy
  • NRSN Buy
  • Analyst Count
  • MOGO 1
  • NRSN 2
  • Target Price
  • MOGO $4.00
  • NRSN $14.00
  • AVG Volume (30 Days)
  • MOGO 145.7K
  • NRSN 197.1K
  • Earning Date
  • MOGO 11-07-2025
  • NRSN 12-17-2025
  • Dividend Yield
  • MOGO N/A
  • NRSN N/A
  • EPS Growth
  • MOGO N/A
  • NRSN N/A
  • EPS
  • MOGO 0.22
  • NRSN N/A
  • Revenue
  • MOGO $29,070,494.00
  • NRSN N/A
  • Revenue This Year
  • MOGO $61.97
  • NRSN N/A
  • Revenue Next Year
  • MOGO $6.28
  • NRSN N/A
  • P/E Ratio
  • MOGO $6.22
  • NRSN N/A
  • Revenue Growth
  • MOGO N/A
  • NRSN N/A
  • 52 Week Low
  • MOGO $0.74
  • NRSN $0.80
  • 52 Week High
  • MOGO $3.83
  • NRSN $2.60
  • Technical
  • Relative Strength Index (RSI)
  • MOGO 26.42
  • NRSN 30.12
  • Support Level
  • MOGO $1.47
  • NRSN $1.02
  • Resistance Level
  • MOGO $1.55
  • NRSN $1.14
  • Average True Range (ATR)
  • MOGO 0.07
  • NRSN 0.07
  • MACD
  • MOGO -0.02
  • NRSN -0.02
  • Stochastic Oscillator
  • MOGO 16.30
  • NRSN 10.13

About MOGO Mogo Inc.

Mogo Inc is a Canadian-based financial technology company. It offers a finance application to consumers with solutions that help them to control their financial health. At Mogo, users can sign up for a free account and get access to products and solutions that help users to monitor their credit score, protect themselves from identity fraud, control their spending, and borrow responsibly. Company offers digital loans and mortgages and also offer a digital payments platform that powers next-generation card programs for both established world-wide corporations and fintech companies in Europe and Canada.

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

Share on Social Networks: